Literature DB >> 7061707

Extraction of vitamin D metabolites by bones of normal adult dogs.

K Olgaard, J Schwartz, D Finco, M Arbelaez, J Haddad, L Avioli, S Klahr, E Slatopolsky.   

Abstract

Using the isolated perfused canine tibia we examined the extraction of [(3)H]25(OH)D(3), [(3)H]1,25(OH)(2)D(3) and [(3)H]24,25(OH)(2)D(3) by bone of normal adult dogs. The studies were performed with and without vitamin D binding protein (DBP) in the perfusate to examine the effect of protein binding on the extraction of the vitamin D metabolites. An average of 48+/-2% of [(3)H]25(OH)D(3) was extracted by bone, when no DBP was present. However, addition of only a small amount of DBP ( approximately 720 ng/ml of perfusate) nearly completely abolished the extraction of [(3)H]25(OH)D(3) by bone. No degradation and/or transformation of the labeled 25(OH)D(3) could be demonstrated during passage through the isolated perfused bone. The extraction of [(3)H]24,25(OH)(2)D(3) in a DBP-free medium averaged 33+/-5%. Addition of 720 ng of DBP/ml of perfusate completely inhibited the extraction of this metabolite. The extraction of [(3)H]1,25(OH)(2)D(3) averaged 30+/-3% in a DBP free medium and no inhibition of the extraction was demonstrated after addition of DBP (720 ng/ml of perfusate). However, addition of DBP in a concentration of 14.4 mug/ml of perfusate reduced the extraction of 1,25(OH)(2)D(3) to 8+/-2%, a value still significantly higher than that seen after addition of 20 times less DBP to perfusions with 25(OH)D(3) and 24,25(OH)(2)D(3). It is concluded that the isolated perfused bone of normal dogs can extract significant amounts of 25(OH)D(3), 1,25(OH)(2)D(3), and 24,25(OH)(2)D(3). Small concentrations of DBP (720 ng/ml) in the perfusate significantly inhibited the extraction of 25(OH)D(3) and 24,25(OH)(2)D(3). A carrier role for DBP is suggested and it is proposed that the levels of free vitamin D are important for extraction of the metabolites by bone. Therefore, due to the different affinities of DBP for the various metabolites of vitamin D, only 1,25(OH)(2)D(3) is extracted in vitro in significant amounts by bone of normal adult dogs, in the presence of DBP.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7061707      PMCID: PMC371026          DOI: 10.1172/jci110496

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Dissociation of specific binding of 25-OH-D3 and resorption in fetal rat bones.

Authors:  A M Mellow; G V Stosich; P H Stern
Journal:  Mol Cell Endocrinol       Date:  1978-04       Impact factor: 4.102

2.  Response of chick parathyroid glands to the vitamin D metabolites, 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol.

Authors:  H L Henry; A N Taylor; A W Norman
Journal:  J Nutr       Date:  1977-10       Impact factor: 4.798

3.  A specific high-affinity binding macromolecule for 1,25-dihydroxyvitamin D3 in fetal bone.

Authors:  B E Kream; M Jose; S Yamada; H F DeLuca
Journal:  Science       Date:  1977-09-09       Impact factor: 47.728

4.  The measurement of the vitamin D-binding protein in human serum.

Authors:  R Bouillon; H van Baelen; P de Moor
Journal:  J Clin Endocrinol Metab       Date:  1977-08       Impact factor: 5.958

5.  Enzymatic radioiodination of gonadotropins.

Authors:  Y Miyachi; J L Vaitukaitis; E Nieschlag; M B Lipsett
Journal:  J Clin Endocrinol Metab       Date:  1972-01       Impact factor: 5.958

6.  Acute administration of 25-hydroxycholecalciferol in man.

Authors:  J G Haddad; S Rojanasathit
Journal:  J Clin Endocrinol Metab       Date:  1976-02       Impact factor: 5.958

7.  25-Hydroxyvitamin D transport in human plasma. Isolation and partial characterization of calcifidiol-binding protein.

Authors:  J G Haddad; J Walgate
Journal:  J Biol Chem       Date:  1976-08-25       Impact factor: 5.157

8.  Inhibition of parathyroid hormone secretion by 25-hydroxycholecalciferol and 24,25-dihydroxycholecalciferol in the dog.

Authors:  J M Canterbury; S Lerman; A J Claflin; H Henry; A Norman; E Reiss
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

9.  Effects of 25-hydroxycholecalciferol on bone lesions of children with terminal renal failure.

Authors:  G Witmer; A Margolis; O Fontaine; J Fritsch; G Lenoir; M Broyer; S Balsan
Journal:  Kidney Int       Date:  1976-11       Impact factor: 10.612

10.  The localization of 1,25-dihydroxycholecalciferol in bone cell nuclei of rachitic chicks.

Authors:  J C Weber; V Pons; E Kodicek
Journal:  Biochem J       Date:  1971-11       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.